Efficacy and Safety of Aflibercept as Mono-therapy in Treat and Extend Regimen for DME Patients in Taiwan

NCT04288232 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

45

Enrollment

OTHER_GOV

Sponsor class

Conditions

Center-involved Diabetic Macular Edema

Interventions

DRUG: Aflibercept Injection [Eylea]

Sponsor

Taipei Veterans General Hospital, Taiwan

Collaborators

[object Object]
[object Object]
[object Object]